Calton & Associates, Inc. Iovance Biotherapeutics, Inc. Transaction History

Calton & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$3.3 - $8.89 $39,897 - $107,480	12,090 New	12,090 $98,000
Q1 2021 May 03, 2021	SELL	$28.67 - $52.59 $129,015 - $236,655	-4,500 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$28.04 - $50.26 $126,180 - $226,170	4,500 New	4,500 $209,000

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.